Biocytogen is proud to participate in the ARE and BVS Sustainability Expo at One Kendall Square in Cambridge, MA, on April 15, 2025! This event gathers sustainability-focused biotech professionals from across the region to share ideas, solutions, and technologies. See how our fully human antibody discovery platforms and preclinical services are helping advance sustainable research worldwide. See you in Kendall Square!
What is the ARE and BVS Sustainability Expo?
The ARE and BVS Sustainability Expo is part of a multi-site Earth Day Road Show hosted by Alexandria Real Estate and BVS. This initiative brings together the biotech community to spotlight sustainable innovations, promote environmentally responsible practices, and create valuable networking opportunities across leading life science campuses in Massachusetts.
Event Overview
Date: April 15, 2025 | Time: 11:00 AM – 1:30 PM
Venue: B600/700 Atrium, One Kendall Square, Cambridge, MA
Event Schedule
For more event information, please refer to BVS.
About BIOCYTOGEN
Biocytogen is a global biotechnology company that drives the research and development of novel antibody-based drugs with innovative technologies. Founded on gene editing technology, Biocytogen leverages genetically engineered proprietary RenMice® platforms for fully human monoclonal antibody discovery, and has established a sub-brand, RenBiologics™, to explore global partnerships for an off-the-shelf library of >400,000 fully human antibody sequences against approximately 1000 targets for worldwide collaboration. Biocytogen pioneered the generation of drug target knock-in humanized models for preclinical research, and currently provides a few thousand off-the-shelf animal and cell models under the company's sub-brand, BioMice™, along with preclinical pharmacology and gene-editing services for clients worldwide. Headquartered in Beijing, Biocytogen has branches in China (Haimen Jiangsu, Shanghai), USA(Boston, San Francisco), and Germany (Heidelberg).
We look forward to seeing you in Kendall Square!
